LLY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eli Lilly and Co

Watchlist Manager

Watchlist

Price: 861.7 EUR -0.13%

Market Cap: €819B

E	Eli Lilly and Co SWB:LLY	US
K	Kumiai Chemical Industry Co Ltd TSE:4996	JP
	Saudi Basic Industries Corporation SJSC SAU:2010	SA
	Nippon Suisan Kaisha Ltd TSE:1332	JP
	Adel Kalemcilik Ticaret ve Sanayi AS IST:ADEL.E	TR
A	AstraZeneca PLC SWB:ZEGA	UK
	Orange SA NYSE:ORAN	FR
	Elior Group SA OTC:ELROF	FR
	Viasat Inc NASDAQ:VSAT	US
	United Therapeutics Corp NASDAQ:UTHR	US
U	Ur-Energy Inc AMEX:URG	US
	PDS Biotechnology Corp NASDAQ:PDSB	US

Profitability Summary

Eli Lilly and Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

81%

Gross Margin is Increasing

78% > 83%

Exceptional Operating Margin

47%

Strong 3Y Average Operating Margin

37%

Operating Margin is Increasing

26% > 47%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

21% > 35%

Exceptional Free Cash Flow Margin

14%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

14% > 14%

Exceptional ROE

108%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

21%

ROIC is Increasing

15% > 29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.